Filing Flows › Puma Biotechnology (PBYI) › R&D spending
Puma Biotechnology (PBYI) R&D spending by quarter
Puma Biotechnology's R&D spending was $18.3M in Q3 2026 (third quarter 2026), -3% from Q2 2026. Over the last 7 quarters it ranged from $13.9M (Q1 2025) to $19.8M (Q1 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $18.3M | -3% | +15% |
| Q2 2026 | $18.9M | -5% | +22% |
| Q1 2026 | $19.8M | +18% | +43% |
| Q4 2025 | $16.8M | +6% | — |
| Q3 2025 | $15.9M | +3% | — |
| Q2 2025 | $15.5M | +11% | — |
| Q1 2025 | $13.9M | — | — |
Q3 2026 at a glance
Puma Biotechnology, Q3 2026: revenue $55.1M (+1% year over year), operating margin 9.6%, net earnings $6.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Puma Biotechnology's R&D spending?
Puma Biotechnology's R&D spending was $18.3M in Q3 2026 (third quarter 2026), -3% from Q2 2026.
How has Puma Biotechnology's R&D spending changed?
Over the last 7 quarters it ranged from $13.9M (Q1 2025) to $19.8M (Q1 2026).